Academy Capital Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02K Hold
20,000
﹤0.01% 37
2025
Q4
$1.12K Hold
20,000
﹤0.01% 41
2025
Q3
$1.78K Hold
20,000
﹤0.01% 41
2025
Q2
$1.5K Hold
20,000
﹤0.01% 40
2025
Q1
$2K Hold
20,000
﹤0.01% 39
2024
Q4
$2.4K Hold
20,000
﹤0.01% 41
2024
Q3
$1.96K Hold
20,000
﹤0.01% 32
2024
Q2
$2.52K Hold
20,000
﹤0.01% 34
2024
Q1
$3.66K Hold
20,000
﹤0.01% 32
2023
Q4
$1.92K Hold
20,000
﹤0.01% 33
2023
Q3
$1.69K Hold
20,000
﹤0.01% 32
2023
Q2
$2.26K Hold
20,000
﹤0.01% 35
2023
Q1
$3K Hold
20,000
﹤0.01% 33
2022
Q4
$2.17K Hold
20,000
﹤0.01% 36
2022
Q3
$1K Hold
20,000
﹤0.01% 36
2022
Q2
$1K Hold
20,000
﹤0.01% 37
2022
Q1
$1K Hold
20,000
﹤0.01% 37
2021
Q4
$1K Hold
20,000
﹤0.01% 38
2021
Q3
$1K Hold
20,000
﹤0.01% 39
2021
Q2
$1K Hold
20,000
﹤0.01% 28
2021
Q1
$1K Hold
20,000
﹤0.01% 34
2020
Q4
$1K Hold
20,000
﹤0.01% 28
2020
Q3
$1K Buy
+20,000
New +$1K ﹤0.01% 34
2020
Q2
Sell
-20,000
Closed -$1K 39
2020
Q1
$1K Hold
20,000
﹤0.01% 36
2019
Q4
$1K Hold
20,000
﹤0.01% 38
2019
Q3
$1K Hold
20,000
﹤0.01% 39
2019
Q2
$1K Hold
20,000
﹤0.01% 36
2019
Q1
$1K Hold
20,000
﹤0.01% 38
2018
Q4
$1K Hold
20,000
﹤0.01% 38
2018
Q3
$1K Buy
+20,000
New +$1K ﹤0.01% 37
2018
Q2
Sell
-20,000
Closed -$1K 42
2018
Q1
$1K Hold
20,000
﹤0.01% 39
2017
Q4
$1K Hold
20,000
﹤0.01% 36
2017
Q3
$0 Buy
+20,000
New ﹤0.01% 40
2016
Q4
Sell
-20,000
Closed -$1K 42
2016
Q3
$1K Hold
20,000
﹤0.01% 41
2016
Q2
$6K Hold
20,000
﹤0.01% 43
2016
Q1
$7K Buy
+20,000
New +$8.24K ﹤0.01% 42
2014
Q3
Sell
-20,000
Closed -$17K 43
2014
Q2
$17K Buy
+20,000
New +$24K ﹤0.01% 40

Other funds holding PVCT

Academy Capital Management's PVCT Position: Q1 2026 in Review

Academy Capital Management held its PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) position steady in Q1 2026 at 20,000 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #37.

Academy Capital Management first reported a position in PVCT in Q2 2014 and has held it in 37 quarters since. The position peaked at $17K in Q2 2014. 6 funds tracked by Wall St. Rank hold PVCT as of Q1 2026.

  • Academy Capital Management held 20,000 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) worth $1.02K as of Q1 2026.
  • Academy Capital Management left its PROVECTUS BIOPHARMACEUTICALS, INC. (DE) share count unchanged in Q1 2026.
  • PROVECTUS BIOPHARMACEUTICALS, INC. (DE) made up ﹤0.01% of Academy Capital Management's portfolio in Q1 2026, its #37 holding.
  • Academy Capital Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and has held it in 37 quarters since.
  • Academy Capital Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $17K in Q2 2014.
  • 6 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2026.

Based on Academy Capital Management's 13F filing for Q1 2026, filed 14 May 2026.